145 related articles for article (PubMed ID: 33417636)
1. C-Reactive Protein, Fibrinogen, Leptin, and Adiponectin Levels in Women with Polycystic Ovary Syndrome.
Ozgokce C; Elci E; Yildizhan R
J Obstet Gynaecol India; 2020 Dec; 70(6):490-496. PubMed ID: 33417636
[TBL] [Abstract][Full Text] [Related]
2. L:A ratio, Insulin resistance and metabolic risk in women with polycystic ovarian syndrome.
Gupta V; Mishra S; Mishra S; Gupta V
Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S697-S701. PubMed ID: 28529126
[TBL] [Abstract][Full Text] [Related]
3. Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters.
Sieminska L; Marek B; Kos-Kudla B; Niedziolka D; Kajdaniuk D; Nowak M; Glogowska-Szelag J
J Endocrinol Invest; 2004 Jun; 27(6):528-34. PubMed ID: 15717649
[TBL] [Abstract][Full Text] [Related]
4. Leptin-to-adiponectin, adiponectin-to-leptin ratios, and insulin are specific and sensitive markers associated with polycystic ovary syndrome: a case-control study from Bahrain.
Golbahar J; Das NM; Al-Ayadhi MA; Gumaa K
Metab Syndr Relat Disord; 2012 Apr; 10(2):98-102. PubMed ID: 22107332
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin and leptin in overweight/obese and lean women with polycystic ovary syndrome.
Chen CI; Hsu MI; Lin SH; Chang YC; Hsu CS; Tzeng CR
Gynecol Endocrinol; 2015 Apr; 31(4):264-8. PubMed ID: 25423261
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome.
Carmina E; Chu MC; Moran C; Tortoriello D; Vardhana P; Tena G; Preciado R; Lobo R
Fertil Steril; 2008 Mar; 89(3):642-8. PubMed ID: 17562334
[TBL] [Abstract][Full Text] [Related]
7. The association of hs-CRP and fibrinogen with anthropometric and lipid parameters in non-obese adolescent girls with polycystic ovary syndrome.
Mažibrada I; Djukić T; Perović S; Plješa-Ercegovac M; Plavšić L; Bojanin D; Bjekić-Macut J; Simić PD; Simić T; Savić-Radojević A; Mastorakos G; Macut D
J Pediatr Endocrinol Metab; 2018 Nov; 31(11):1213-1220. PubMed ID: 30335612
[TBL] [Abstract][Full Text] [Related]
8. [Correlations between adipocytokines and insulin resistance in women with polycystic ovary syndrome].
Li X; Li X; Huang HY; Ma D; Zhu MW; Lin JF
Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2607-10. PubMed ID: 20137676
[TBL] [Abstract][Full Text] [Related]
9. Validity of adiponectin-to-leptin and adiponectin-to-resistin ratios as predictors of polycystic ovary syndrome.
Sarray S; Madan S; Saleh LR; Mahmoud N; Almawi WY
Fertil Steril; 2015 Aug; 104(2):460-6. PubMed ID: 26051098
[TBL] [Abstract][Full Text] [Related]
10. The adiponectin-to-leptin ratio in women with polycystic ovary syndrome: relation to insulin resistance and proinflammatory markers.
Xita N; Papassotiriou I; Georgiou I; Vounatsou M; Margeli A; Tsatsoulis A
Metabolism; 2007 Jun; 56(6):766-71. PubMed ID: 17512308
[TBL] [Abstract][Full Text] [Related]
11. Altered leptin, adiponectin, resistin and ghrelin secretion may represent an intrinsic polycystic ovary syndrome abnormality.
Baldani DP; Skrgatic L; Kasum M; Zlopasa G; Kralik Oguic S; Herman M
Gynecol Endocrinol; 2019 May; 35(5):401-405. PubMed ID: 30623695
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Role of Ghrelin and Leptin as Biochemical Markers in Female with Polycystic Ovarian Syndrome.
Ibrahim MK; Alobaidi AHA
Antiinflamm Antiallergy Agents Med Chem; 2021; 20(4):373-379. PubMed ID: 33888052
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin and leptin levels in normal weight women with polycystic ovary syndrome.
Gözüküçük M; Yarcı Gürsoy A; Destegül E; Taşkın S; Şatıroğlu H
Horm Mol Biol Clin Investig; 2020 May; 41(4):. PubMed ID: 32364518
[TBL] [Abstract][Full Text] [Related]
14. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
Arikan S; Bahceci M; Tuzcu A; Kale E; Gökalp D
Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
[TBL] [Abstract][Full Text] [Related]
15. Evidence for altered adipocyte function in polycystic ovary syndrome.
Carmina E; Orio F; Palomba S; Cascella T; Longo RA; Colao AM; Lombardi G; Lobo RA
Eur J Endocrinol; 2005 Mar; 152(3):389-94. PubMed ID: 15757855
[TBL] [Abstract][Full Text] [Related]
16. Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
Pangaribuan B; Yusuf I; Mansyur M; Wijaya A
Ther Adv Endocrinol Metab; 2011 Dec; 2(6):235-45. PubMed ID: 23148188
[TBL] [Abstract][Full Text] [Related]
17. Adipocytokine profiles in a putative novel postmenopausal polycystic ovary syndrome (PCOS) phenotype parallel those in premenopausal PCOS: the Rancho Bernardo Study.
Krentz AJ; von Mühlen D; Barrett-Connor E
Metabolism; 2012 Sep; 61(9):1238-41. PubMed ID: 22560129
[TBL] [Abstract][Full Text] [Related]
18. Prediction of metabolic syndrome in women with polycystic ovary syndrome.
Ersan F; Arslan E; Esmer AÇ; Aydın S; Gedikbaşı A; Gedikbaşı A; Alkış I; Ark C
J Turk Ger Gynecol Assoc; 2012; 13(3):178-83. PubMed ID: 24592034
[TBL] [Abstract][Full Text] [Related]
19. Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention.
Moran LJ; Meyer C; Hutchison SK; Zoungas S; Teede HJ
J Endocrinol Invest; 2010 Apr; 33(4):258-65. PubMed ID: 19834313
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls.
Glintborg D; Andersen M; Hagen C; Frystyk J; Hulstrøm V; Flyvbjerg A; Hermann AP
Eur J Endocrinol; 2006 Aug; 155(2):337-45. PubMed ID: 16868149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
